Chemoinformaics analysis of 2,3-Diphenylbenzofuran
| Molecular Weight | 270.331 | nRot | 2 |
| Heavy Atom Molecular Weight | 256.219 | nRig | 22 |
| Exact Molecular Weight | 270.104 | nRing | 4 |
| Solubility: LogS | -6.542 | nHRing | 1 |
| Solubility: LogP | 5.651 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 3 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 21 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 22 |
| nHA | 1 | APOL | 43.5371 |
| nHD | 0 | BPOL | 15.7809 |
| QED | 0.451 |
| Synth | 1.657 |
| Natural Product Likeliness | 0.192 |
| NR-PPAR-gamma | 0.889 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.969 |
| Pgp-sub | 0.211 |
| HIA | 0.004 |
| CACO-2 | -4.741 |
| MDCK | 0.0000177 |
| BBB | 0.057 |
| PPB | 0.992901 |
| VDSS | 0.733 |
| FU | 0.00669487 |
| CYP1A2-inh | 0.991 |
| CYP1A2-sub | 0.177 |
| CYP2c19-inh | 0.834 |
| CYP2c19-sub | 0.063 |
| CYP2c9-inh | 0.509 |
| CYP2c9-sub | 0.867 |
| CYP2d6-inh | 0.041 |
| CYP2d6-sub | 0.402 |
| CYP3a4-inh | 0.159 |
| CYP3a4-sub | 0.196 |
| CL | 6.876 |
| T12 | 0.057 |
| hERG | 0.016 |
| Ames | 0.505 |
| ROA | 0.084 |
| SkinSen | 0.185 |
| Carcinogencity | 0.695 |
| EI | 0.943 |
| Respiratory | 0.033 |
| NR-Aromatase | 0.893 |
| Antiviral | No |
| Prediction | 0.58577 |